Sungjoon Chae
Co-CEO & DirectorMr. Sungjoon Chae is Co-Chief Executive Officer of Apimeds Pharmaceuticals US, Inc. from May 4, 2026 and serves as its Director since September 10, 2026. Mr. Chae was Director of Yoshiharu Global Co. from March 17, 2025 until May 22, 2025. Mr. Chae is a distinguished architect and urban designer dedicated to shaping sustainable and innovative spaces that enhance the human experience. With a deep understanding of the interplay between space, architecture and urban environments, he has consistently delivered designs that merge aesthetic appeal with functionality. Mr. Chae is CEO of Grundot and a former adjunct professor at Hongik University. Mr. Chae has amassed extensive experience working with some of the world's most renowned architectural firms, including Steven Holl Architects, Weiss/Manfredi and Michael Maltzan Architecture, where he played a key role as a Senior Designer and Project Designer. His portfolio spans a diverse range of high-profile projects, such as the 94-unit apartment building Meander in Helsinki, Finland, the Franklin & Marshall Fine Arts Building in Lancaster, PA, the Tulane University Dining Common in New Orleans, the master plan for the U.S. Embassy in New Delhi, India and the Malibu Beach House in California. Mr. Chae holds a Master of Architecture in Urban Design from the Harvard Graduate School of Design in 2013 and a Master and Bachelor of Architecture from the Illinois Institute of Technology.
Positions
- Company NameApimeds Pharmaceuticals US, Inc.Stock CodeAPUSPositionCo-CEO & Director
